Application of transcranial sonography in extrapyramidal disorders: Updated recommendations

Ultraschall in der Medizin

Volumn 27, Issue 1, 2006, Pages 12-19

  Berg, Daniela ^a   Behnke, S ^b   Walter, U ^c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Extrapyramdial disorders; Lentiform nucleus hyperechogenicity; Standardised scanning planes; Substantia nigra hyperechogenicity; Transcranial sonography (TCS)

Indexed keywords

DOPAMINE; FLUORINE DERIVATIVE; IODINE 123;

BRAIN FUNCTION; BRAIN REGION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DOPPLER ECHOGRAPHY; DYSTONIA; EXTRAPYRAMIDAL SYNDROME; FUNCTIONAL ANATOMY; HUMAN; LENTIFORM NUCLEUS; NEUROANATOMY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; REVIEW; SUBSTANTIA NIGRA;

EID: 33644758218     PISSN: 01724614     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858962     Document Type: Review

References (41)

1. Walter U, Behnke S, Eyding J et al. Transcranial sonography of the brain parenchyma in movement disorders: state of the art. Mov Disord 2005, in press
2. Becker G, Berg D. Neuroimaging in basal ganglia disorders: perspectives for transcranial ultrasound. Mov Disord 2001; 16: 23-32
3. Puls I, Berg D, Maurer M et al. Transcranial sonography of the brain parenchyma: comparison of B-mode imaging and tissue harmonic imaging. Ultrasound Med Biol 2000; 26: 189-194
4. Bogdahn U, Becker G, Schlachetzki F. Echoenhancers and transcranial color duplex sonography. Berlin, Vienna: Blackwell Science, 1998
5. Berg D, Becker G, Zeiler B et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999; 53: 1026-1031
6. Berg D, Siefker C, Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 2001; 8: 684-689
7. Walter U, Wittstock M, Benecke R et al. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm 2002; 109: 191-196
8. Behnke S, Becker G. Sonographic imaging of the brain parenchyma. Eur J Ultrasound 2002; 16: 73-80
9. Becker G, Struck M, Bogdahn U et al. Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res 1994; 55: 75-84
10. Becker G, Seufert J, Bogdahn U et al. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995; 45: 182-184
11. Berg D, Supprian T, Hofmann E et al. Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol 1999
12. Walter U, Dressler D, Wolters A et al. Overactive bladder in Parkinson's disease: alteration of brainstem raphe detected by transcranial sonography. Eur J Neurol 2005; in press
13. Becker G, Naumann M, Scheubeck M et al. Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis. Mov Disord 1997; 12: 79-88
14. Postert T, Lack B, Kuhn W et al. Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography. J Neurol Neurosurg Psychiatry 1999; 67: 457-462
15. Postert T, Eyding J, Berg D et al. Transcranial sonography in spinocerebellar ataxia type 3. J Neural Transm 2004; 68 (Suppl): 123-133
16. Tromp S, Vlaar A, Weber W et al. Can ultrasonography of the substantia nigra replace FP-CIT-CPECT. Parkinsonism Rel Dis 2005; 11: 221
17. Zedde M, Manca A, Baule G et al. Brain parenchyma sonography (BPS) of substantia nigra (SN) in Parkinson's disease. Parkinsonism Rel Dis 2005; 11: 222
18. Walter U, Klein C, Milker R et al. Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord 2004; 19: 1445-1449
19. Berg D, Grote C, Rausch WD et al. Iron accumulation of the substantia nigra in rats visualized by ultrasound. Ultrasound Med Biol 1999; 25: 901-904
20. Berg D, Roggendorf W, Schröder U et al. Echogenicity of the substantia nigra - association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002; 59: 999-1005
21. Zecca L, Berg D, Arzberger T et al. In vivo detection of iron and neuromelanin by transcranial sonography: A new approach for early detection of substantia nigra damage. Mov Disord 2005 Jun 28; [Epub ahead of print]
22. Berg D, Merz B, Reiners K et al. A five year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord, 2005; 20: 383-385
23. Niehaus L, Savyer N, Weber U et al. Brain parenchyma sonography in patients with essential tremor and Parkinson's disease. Cerebrovasc Dis 2004; 17 (Suppl 4): 3
24. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114: 2283-2301
25. Berg D, Siefker C, Ruprecht-Dorfler P et al. Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology 2001; 56: 13-17
26. Berg D, Jabs B, Merschdorf U et al. Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of Parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry 2001; 50: 463-467
27. Sommer U, Hummel T, Cormann K et al. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 2004; 19: 1196-1202
28. Naumann M, Becker G, Toyka KV et al. Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology 1996; 47: 1284-1290
29. Becker G, Berg D, Rausch WD et al. Increased tissue copper and manganese content of the lentiform nucleus in primary adult-onset dystonia. Ann Neurol 1999; 46: 260-263
30. Berg D, Weishaupt A, Francis MJ et al. Changes of copper transporting proteins and ceruloplasmin in the lentiform nuclei in primary adult-onset dystonia. Ann Neurol 2000; 47: 827-830
31. Walter U, Krolikowski K, Tarnacka B et al. Sonographic detection of basal ganglia abnormalities in asymptomatic and symptomatic Wilson disease. Neurology 2005; 64: 1726-1732
32. Kruse N, Berg D, Francis MJ et al. Reduction of Menkes mRNA and copper in leukocytes of patients with primary adult-onset dystonia. Ann Neurol 2001; 49: 405-408
33. Berg D, Naumann M, Hoggenmüller U et al. Differences of echogenicity and T2 relaxation time of the nucleus lentiformis in MSA and PSP as compared to Parkinson's disease. Mov Disord 2000; 15 (suppl 3): 206
34. Walter U, Niehaus L, Probst T et al. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 2003; 60: 74-77
35. Walter U, Dressler D, Wolters A et al. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology 2004; 63: 504-509
36. Behnke S, Berg D, Naumann M et al. Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 2005; 76: 423-425
37. Dexter DT, Jenner P, Schapira AHV et al. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. Ann Neurol 1992; 32 (Suppl): S94-100
38. Walter U, Dressler D, Wolters A et al. Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia. J Neurol 2005, in press
39. Durr A, Stevanin G, Cancel G et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol 1996; 39: 490-499
40. Hochstrasser H, Bauer P, Walter U et al. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology 2004; 63: 1912-1917
41. Hochstrasser H, Tomiuk J, Walter U et al. Functional relevance of ceruloplasmin mutations in Parkinson's Disease. FASEB J 2005; 19: 1851-1853